News (73)

Vertex Presents New Data at the European Cystic Fibrosis Conference Demonstrating Significant Benefits of Treatment with TRIKAFTA® BU
Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older BU
Vertex Announces Advancements of Suzetrigine in Acute and Neuropathic Pain AQ
Vertex Announces Advancements of Suzetrigine (VX-548) in Acute and Neuropathic Pain BU
Vertex Advances Inaxaplin into Phase 3 Portion of Adaptive Phase 2/3 Clinical Trial for the Treatment of APOL1-Mediated Kidney Disease AQ
Vertex Advances Inaxaplin (VX-147) into Phase 3 Portion of Adaptive Phase 2/3 Clinical Trial for the Treatment of APOL1-Mediated Kidney Disease BU
Vertex Announces FDA Clearance of Investigational New Drug Application for VX-407 for the Treatment of Autosomal Dominant Polycystic Kidney Disease AQ
Vertex Announces FDA Clearance of Investigational New Drug Application for VX-407 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) BU
Next-in-class combination treatment shows potential in cystic fibrosis AQ
Vertex Announces Positive Results From Pivotal Trials of Vanzacaftor, Tezacaftor, Deutivacaftor, Next-In-Class Triple Combination Treatment for Cystic Fibrosis AQ
Vertex Announces Positive Results From Pivotal Trials of Vanzacaftor/Tezacaftor/Deutivacaftor, Next-In-Class Triple Combination Treatment for Cystic Fibrosis BU
Vertex Announces Positive Results From Phase 2 Study of VX-548 for the Treatment of Painful Diabetic Peripheral Neuropathy BU
Positive Results from Pivotal Trials of CASGEVY™ (exagamglogene autotemcel) Highlighted in Oral Presentations at the American Society of Hematology (ASH) Annual Meeting and Exposition BU
Vertex Pharmaceuticals - European Commission Approves KAFTRIO in Combination with Ivacaftor for the Treatment of Children with Cystic Fibrosis Ages 2 Through 5 AQ
Vertex Pharmaceuticals Cystic Fibrosis Treatment Approved for Young Children in EU DJ
European Commission Approves KAFTRIO® in Combination With Ivacaftor for the Treatment of Children With Cystic Fibrosis Ages 2 Through 5 BU
Vertex to Present Data Highlighting Long-Term Benefits of TRIKAFTA at the North American Cystic Fibrosis Conference AQ
Vertex to Present Data Highlighting Long-Term Benefits of TRIKAFTA® at the North American Cystic Fibrosis Conference BU
Vertex Presents Positive, Updated VX-880 Results From Ongoing Phase 1/2 Study in Type 1 Diabetes at the European Association for the Study of Diabetes 59th Annual Meeting BU
Vertex Announces Publication of VX-548 Positive Phase 2 Proof-of-Concept Results in New England Journal of Medicine AQ
Vertex Announces Publication of VX-548 Positive Phase 2, Proof-of-Concept Results in New England Journal of Medicine BU
European Commission Approves ORKAMBI® (lumacaftor/ivacaftor) for the Treatment of Children With Cystic Fibrosis Ages 1 to <2 Years Old BU
Vertex Pharmaceuticals - Positive Results from Pivotal Trials of exa-cel for Transfusion-Dependent Beta Thalassemia and Severe Sickle Cell Disease Presented at the 2023 Annual European Hematology Association Congress AQ
Positive Results From Pivotal Trials of exa-cel for Transfusion-Dependent Beta Thalassemia and Severe Sickle Cell Disease Presented at the 2023 Annual European Hematology Association (EHA) Congress BU
Vertex Announces U.S. FDA Approval for KALYDECO to Treat Eligible Infants with CF Ages 1 Month and Older AQ
Vertex Announces U.S. FDA Approval for KALYDECO® (ivacaftor) to Treat Eligible Infants With CF Ages 1 Month and Older BU
Vertex Announces U.S. FDA Approval for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in Children With Cystic Fibrosis Ages 2 Through 5 With Certain Mutations BU
CRISPR Therapeutics and Vertex Complete Submission of Rolling Biologics License Applications to the US FDA for exa-cel for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia AQ
CRISPR Therapeutics : Regulation FD Presentation - Form 8-K PU
Vertex and CRISPR Therapeutics Complete Submission of Rolling Biologics License Applications (BLAs) to the US FDA for exa-cel for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia BU
Vertex Announces Publication in New England Journal of Medicine of Results from Phase 2 Study of Inaxaplin AQ
Vertex Announces Publication in New England Journal of Medicine of Results from Phase 2 Study of Inaxaplin (VX-147) BU
Vertex and CRISPR Therapeutics to Present at the American Society of Hematology Annual Meeting and Exposition AQ
Vertex and CRISPR Therapeutics to Present at the American Society of Hematology (ASH) Annual Meeting and Exposition BU
Vertex Announces Partnership with Basketball Hall-of-Famer Alonzo Mourning to Raise Awareness of APOL1-Mediated Kidney Disease AQ
Vertex Announces Partnership with Basketball Hall-of-Famer Alonzo Mourning to Raise Awareness of APOL1-Mediated Kidney Disease (AMKD) BU
Vertex to Present New Data on its Portfolio of Cystic Fibrosis Medicines at the 2022 North American Cystic Fibrosis Conference BU
Vertex Announces U.S. FDA Approval for ORKAMBI® (lumacaftor/ivacaftor) in Children With Cystic Fibrosis Ages 12 to <24 months BU
Vertex Advances VX-548 in Acute and Neuropathic Pain AQ
Vertex Advances VX-548 in Acute and Neuropathic Pain BU
Vertex and CRISPR Therapeutics Present New Data on More Patients With Longer Follow-Up Treated With exagamglogene autotemcel (exa-cel) at the 2022 European Hematology Association (EHA) Congress AQ
Vertex and CRISPR Therapeutics Present New Data on More Patients With Longer Follow-Up Treated With exagamglogene autotemcel (exa-cel) at the 2022 European Hematology Association (EHA) Congress BU
Vertex to Present Data Demonstrating Significant Benefits of Long-Term and Early Treatment With CFTR Modulators at the European Cystic Fibrosis Conference BU
Vertex Provides Updates on Phase 1/2 Clinical Trial of VX-880 for the Treatment of Type 1 Diabetes BU
Vertex Announces Statistically Significant and Clinically Meaningful Results From Two Phase 2 Proof-of-Concept Studies of VX-548 for the Treatment of Acute Pain BU
12NextSee all

Companies (8)

TECK RESOURCES LIMITED 24 771 M $
Logo Teck Resources Limited

Teck Resources Limited is a Canada-based mining company that operates in copper, zinc, steelmaking coal and energy segment. The Company’s operations and projects include Antamina, Cardinal River, Carmen de Andacollo, Elkview, Fording River, Fording Rive ...

SIGNATURE EYEWEAR, INC. 6 $
Logo Signature Eyewear, Inc.

Signature Eyewear, Inc. is an eyewear company. The Company provides eyewear to opticians, optometrists and ophthalmologists. Its brands include Bobby Jones, Carmen Marc Valvo, Cutter & Buck, CEO-V, Dakota Smith, Hart Schaffner Marx, Hickey Freeman, Laura ...

FIBRA PLUS 284 M $
Logo Fibra Plus

Fibra Plus is a Mexico-based company engaged in the operation of real estate development trust (REIT). The Company focuses on the acquisition, development, management and rental of commercial properties in Mexico. The Company's real estate portfolio compr ...

ATLAS CONSOLIDATED MINING AND DEVELOPMENT CORPORATION 285 M $
Logo Atlas Consolidated Mining and Development Corporation

Atlas Consolidated Mining and Development Corporation is a Philippines-based diversified natural resource-based company. The Company is engaged in metallic mineral mining and exploration and produces copper concentrate (with gold and silver). Its two oper ...

UNIVANICH PALM OIL 213 M $
Logo Univanich Palm Oil

Univanich Palm Oil Public Company Limited is a Thailand-based producer of crude palm oils and oil palm seeds. The Company is engaged in oil palm plantations, crushing mills, oil palm research and seed businesses and an electric power plant with a methane ...

KNOT OFFSHORE PARTNERS LP 236 M $
Logo KNOT Offshore Partners LP

KNOT Offshore Partners LP is a United Kingdom-based company that owns, operates and acquires shuttle tankers primarily under long-term charters in the offshore oil production regions of Brazil and the North Sea. The Company's fleet consists of approximate ...

BW OFFSHORE LIMITED 491 M $
Logo BW Offshore Limited

BW Offshore Limited is a Bermuda-based holding company, which engineers advanced floating production solutions. The Company has a fleet of approximately three floating, production, storage, and offloading vessels (FPSOs) with the potential to grow. The Co ...

HERENCIA RESOURCES PLC 1 M $
Logo Herencia Resources Plc

Herencia Resources plc (Herencia) is engaged in mineral exploration and development. The Company holds a portfolio of copper-silver and zinc-silver-lead-copper-gold properties in Chile, South America. The Company's segments include Mineral Exploration and ...


Insiders

Picture Carmen Bozic
Carmen Bozic

Carmen Bozic is Chief Medical Officer & EVP-Medical Affairs at Vertex Pharmaceuticals, Inc. In her past career Dr. Bozic occupied the position of Senior Vice President-Global Development at Biogen, Inc. She received a doctorate from McGill University.



Picture Carmen Perez
Carmen Perez

Carmen Perez currently works as a Vice President-Operations at Canadian Apartment Properties Real Estate Investment Trust.


Picture Carmen Maria Velthuis
Carmen Maria Velthuis

Carmen Maria Velthuis is currently the Managing Director at Vodafone Deutschland GmbH.
She is also the Co-Managing Director & Member-Management Board at Vodafone GmbH.
Additionally, she holds the position of Director at Vodafone România SA, Vodafone Telekomünikasyon AS, and Vodafone Libertel BV.
Ms. Velthuis is the Chief Financial Officer at Kabel Deutschland Holding AG and a Member-Supervisory Board at Enexis Holding NV and VodafoneZiggo Group BV.
She completed her undergraduate degree at the University of Groningen.


Picture Carmen Rando Bejar
Carmen Rando Bejar

Carmen Rando Bejar is currently working as the Chief People Officer at Schlumberger NV.
Prior to this role, Ms. Rando Bejar has completed an undergraduate degree at Heriot-Watt University, a graduate degree at Icade Business School, and another graduate degree at Universidad Pontificia Comillas.


Picture Manita Carmen A Gonsalves
Manita Carmen A Gonsalves

Currently, Manita Carmen A Gonsalves occupies the position of Secretary & Compliance Officer for Polycab India Ltd. In the past Ms. Gonsalves occupied the position of Secretary & Assistant General Manager-Legal at Amcor Rigid Plastics India Pvt Ltd. Ms. Gonsalves received a graduate degree from Jitendra Chohan College of Law.


Picture Carmen Judyth Romero López
Carmen Judyth Romero López

Presently, Carmen Judyth Romero López is Compliance Officer for Banco Nacional de Credito CA.


Picture Carmen de Pablo Redondo
Carmen de Pablo Redondo

Carmen de Pablo Redondo is currently the Chief Financial Officer at Compañía Española de Petróleos SA. Previously, she held positions as an Executive Director in Investment Banking at J.P.
Morgan & Co. Ltd., Lehman Brothers UK Holdings Ltd., and Morgan Stanley & Co. Ltd.
She also served as an Independent Director at Viscofán SA from 2020 to 2023 and as the Chief Financial Officer & Financial Manager at Gestamp Automoción SA from 2019 to 2021.
Ms. de Pablo Redondo started her career as an Associate at McKinsey & Co. (Spain).
She completed her undergraduate studies at Colegio Universitario de Estudios Financieros and obtained an MBA from Tuck School of Business at Dartmouth.

















Picture Kevin J. Bozic
Kevin J. Bozic

Kevin J.
Bozic
is currently the Director at the American Academy of Orthopaedic Surgeons.
He has an undergraduate degree from Duke University, a doctorate from The University of California, San Francisco, and an MBA from Harvard Business School.


Picture Matjaz Bozic
Matjaz Bozic

Matjaz Bozic currently works as a Chief Executive Officer at Lovcen osiguranju AD Podgorica.







Picture Dragiša Božic
Dragiša Božic

Dragiša Božic worked as a Finance Director & Investor Relations Contact at Seme-Tamiš doo and as a General Director at Vojvodina doo.






Picture Marin Bozic
Marin Bozic

Marin Bozic has a current job as a Member-Supervisory Board at Institut IGH dd since 2021.









Picture Ana Božic
Ana Božic

Ana Božic is currently working as the Executive Director-General & Legal Affairs at Hidroelektrane na Drini AD and as the Contact Person-Large Businesses at Hrvatska Poštanska Banka dd.









Picture Chris Bozic
Chris Bozic

Chris Bozic worked as a Vice President-Marketing at Vivos Therapeutics, Inc.




Picture Bozidar Bozic
Bozidar Bozic

Bozidar Bozic was an Independent Director at Zwack Unicum Nyrt.



Picture Michael Bozic
Michael Bozic

Michael Bozic currently works at Morgan Stanley Variable Insurance Fund, Inc., as Independent Director from 1994, Aip Macro Registered Fund A, as Director, AIP MACRO REGISTERED FUND P, as Director, and Hillsdale College, as Trustee.
Mr. Bozic also formerly worked at Hills Department Stores, Inc., as President & Chief Executive Officer in 1995, Levitz Furniture Corp., as Chairman & Chief Executive Officer in 1998, Sears Merchandise Group, as Chairman, President, CEO & COO in 1991, Roebuck & Co., as Chairman, President, CEO & COO in 1991, Kmart Corp., as Vice Chairman in 2000, Morgan Stanley Income Securities, Inc., as Director in 1994, The Latin American Discovery Fund, Inc., as Independent Director from 1994 to 2015, The Malaysia Fund, Inc., as Independent Director from 1994 to 2012, Morgan Stanley Dean Witter Asia Pacific Fund, Inc., as Director, The Thai Fund, Inc., as Director from 1994 to 2012, The Turkish Investment Fund, Inc., as Director in 1994, Weirton Steel Corp., as Director, Morgan Stanley Europe Fund, Inc., as Director, Morgan Stanley China A Share Fund, Inc., as Director in 2006, Morgan Stanley Emerging Markets Domestic Debt Fund, Inc., as Director in 1994, Morgan Stanley Frontier Emerging Markets Fund, Inc., as Director from 1994 to 2012, Morgan Stanley Emerging Markets Fund, Inc., as Director, Morgan Stanley Global Opportunity Bond Fund, Inc., as Director from 1994 to 2010, Morgan Stanley High Yield Fund, Inc., as Director, Morgan Stanley Emerging Markets Debt Fund, Inc., as Independent Director, Morgan Stanley Asia-Pacific Fund, Inc., as Director from 1994 to 2012, and Morgan Stanley California Insured Municipal Income Trust, as Trustee from 1994 to 2010.


Picture Scott Bozic
Scott Bozic

Scott Bozic has held the following positions in his career: Chief Operating & Revenue Officer at Canary Technology Solutions Pty Ltd.
and Senior Managing Partner at System Partners Pty Ltd.
He is currently employed in both of these roles.







Picture Slavko Bozic
Slavko Bozic

Slavko Bozic has worked as a Member-Supervisory Board at Istra dd since 2012.







Picture Karen Bozic
Karen Bozic

Karen Bozic is currently the Group Chief Executive Officer & Director at Quick Service Restaurant Holdings Pty Ltd.
She is also a Director at Big W.
In the past, she worked at Woolworths Group Ltd.
as the General Manager-Replenishment, Food & Liquor from 2015 to 2016.


Picture Zana Božic
Zana Božic

Zana Božic currently works as a Secretary at Jadroplov dd.






Picture Carmen J. Putrelo
Carmen J. Putrelo

Carmen J.
Putrelo
currently works as a Director of Administrative Services at Utica Mutual Insurance Co.




Picture Carmen Mariscal
Carmen Mariscal

Carmen Diaz Mariscal joined Two Connect, Inc. in 1995 and currently serves as Chief Financial Officer.
She was a Financial Analyst of International Business Machines Corp.
and Lexmark Latinamerica from 1990 to 1995.
Ms. Mariscal received a Bachelors degree in Marketing and Management in 1992 and an MBA in 1995 from the University of Miami.





Picture Carmen Carey
Carmen Carey

Carmen Christine Carey is currently the Chief Executive Officer at Sorted Holdings Ltd., the Chief Executive Officer & Executive Director at Sorted Group Holdings Plc, the Director at Sorted Group Ltd., and the Director at Clicksit App Ltd.
Previously, she held positions such as Chief Executive Officer & Director at Brady Technologies Ltd., Chief Executive Officer at CopperEye Labs Ltd., Chief Executive Officer at Control Circle Ltd., Chief Executive Officer at Apica AB, Chief Executive Officer at Big Data Partnership Ltd., Director-Operations & Product Development at Healthtrac, Inc., Non-Executive Director at Arts Alliance Media Ltd., Chief Operating Officer at MetaPack Ltd., Vice President-Client Services at Caresoft, Inc., Chief Operating Officer at MessageLabs Ltd., and Vice President-Global Services at Broadvision U.K.
Ltd.
Ms. Carey completed her undergraduate and graduate degrees at California State University-Fresno.




Picture Carmen Wayne Shick
Carmen Wayne Shick

Carmen Wayne Shick currently works as the President of Bedford Downs Management Corp.



Picture Carmen Boyero
Carmen Boyero

Carmen Boyero worked as a Research Analyst at Nomura International Plc.












Picture Carmen Julia Aguiar
Carmen Julia Aguiar

Ms. Carmen J.
Aguiar, CPA, is Chairman at Plaza Bank (Washington), President & Chief Executive Officer at Aguiar Group, and a Member-Risk Management Committee at CAMICO Mutual Insurance Co.


Picture Carmen Schneider
Carmen Schneider

Carmen Schneider worked as a Manager-Investor Relations at E.ON SE.

No results for this search